Literature DB >> 6204487

Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies.

E Asbrink, A Hovmark.   

Abstract

The serum levels of IgE were found to be increased in 24 of 34 patients with an acute exacerbation of bullous pemphigoid. There was no statistically significant correlation between the serum IgE level or the serum anti-basement membrane zone antibody titer and the extent of the disease during an exacerbation. There was however a positive correlation between anti-basement membrane zone antibody titers and serum IgE levels. All but 2 patients showed a normalisation or decline in serum IgE 2-4 months after an exacerbation of the disease. There was also a tendency to declining antibasement membrane zone antibody titers in many patients but changes of these titers could usually not be measured as early as alterations of serum IgE levels were found. Thus in most patients serum IgE was found to be a better laboratory parameter than indirect immunofluorescence for following the activity of the disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204487

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  7 in total

1.  The distribution of IgG subclass autoantibodies in bullous pemphigoid analysed by immunofluorescence and immunoblotting.

Authors:  H Soh; H Hosokawa; H Miyauchi; H Izumi; Y Asada
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

3.  IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)

Authors:  R F Ghohestani; E Cozzani; E Delaporte; J F Nicolas; A Parodi; A Claudy
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

4.  Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid.

Authors:  Kelly N Messingham; Heather M Holahan; Alexandra S Frydman; Colleen Fullenkamp; Rupasree Srikantha; Janet A Fairley
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 5.  The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.

Authors:  Kelly N Messingham; Tyler P Crowe; Janet A Fairley
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 6.  IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.

Authors:  Ariadne Hadjikyriacou Saniklidou; Patrick J Tighe; Lucy C Fairclough; Ian Todd
Journal:  Arch Dermatol Res       Date:  2017-10-25       Impact factor: 3.017

7.  High Index Values of Enzyme-Linked Immunosorbent Assay for BP180 at Baseline Predict Relapse in Patients With Bullous Pemphigoid.

Authors:  Hiroshi Koga; Kwesi Teye; Norito Ishii; Chika Ohata; Takekuni Nakama
Journal:  Front Med (Lausanne)       Date:  2018-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.